Mr. Goldberg has served as a director since March 2011. He is a Vice President at Clal Biotechnology Industries (TASE: CBI), leading CBI’s strategic investment decisions and technological development. Mr. Goldberg is also the managing director of Anatomy Medical Technology fund, CBI’s medical device investment arm.
clinical trails